A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." According to the NIH, Alzheimer's disease accounts for up to two-thirds of dementia cases in people 65 ...

In a nutshell: As the global population ages, Alzheimer's disease has become one of the most common forms of dementia affecting older adults. Traditional diagnostic methods are often expensive and ...

New research shows a simple blood test can predict the onset of Alzheimer’s symptoms, leading to earlier therapeutic care Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...

A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin. Researchers at the Washington University School of Medicine in St.

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Grail's Galleri test promises to detect cancer signals in your blood. It's good at finding advanced cancers, but can miss early-stage cases. Telehealth company Hims & Hers is offering Galleri at a ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

A finger-prick blood test that can be mailed to a lab may offer a simpler way to detect the brain changes linked to Alzheimer’s disease, according to a new study. Researchers tested whether tiny ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as the largest population-based assessment of the condition’s ...

There’s new progress in the battle against Alzheimer’s disease. About 1 in 9 US seniors has Alzheimer’s, the most common form of dementia, which slowly impairs memory, thinking skills and the ability ...